Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
36.78
+0.55 (1.52%)
At close: Aug 13, 2025, 4:00 PM
36.78
0.00 (0.00%)
After-hours: Aug 13, 2025, 7:00 PM EDT
Smith & Nephew Revenue
Smith & Nephew had revenue of $2.96B in the half year ending June 28, 2025, with 8.30% growth. This brings the company's revenue in the last twelve months to $5.94B, up 5.35% year-over-year. In the year 2024, Smith & Nephew had annual revenue of $5.81B with 4.70% growth.
Revenue (ttm)
$5.94B
Revenue Growth
+5.35%
P/S Ratio
2.70
Revenue / Employee
$329,125
Employees
18,060
Market Cap
16.04B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.81B | 261.00M | 4.70% |
Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
SNN News
- 6 days ago - Smith & Nephew: Doing Better And Still Offers Value - Seeking Alpha
- 8 days ago - Smith & Nephew plc (SNN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Top 2 Health Care Stocks You May Want To Dump In Q3 - Benzinga
- 5 weeks ago - Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option - GlobeNewsWire
- 7 weeks ago - Smith+Nephew's new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing' to trauma surgeons repairing tibial fractures - GlobeNewsWire
- 7 weeks ago - Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer - GlobeNewsWire
- 2 months ago - Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK - GlobeNewsWire
- 2 months ago - New medial stabilized insert for Smith+Nephew's LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility - GlobeNewsWire